Lovenox (enoxaparin) is now approved to prevent deep vein thrombosis in certain MEDICAL patients
December 2000
Lovenox (enoxaparin) is now approved to prevent deep vein thrombosis in certain MEDICAL patients...not just surgical patients.
This new indication is for patients at risk for thrombosis during an acute illness...due to restricted mobility with other risk factors such as obesity or varicose veins.
Give these patients low-dose heparin...or Lovenox 40 mg once a day for up to 14 days to prevent thromboembolic complications.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote